ARTICLE | Company News
Elan gets EU recommendation for NeuroBloc
November 6, 2000 8:00 AM UTC
ELN said the Committee for Proprietary Medicinal Products recommended approval of NeuroBloc, a botulinum toxin type B that inhibits acetylcholine release, to treat cervical dystonia. ...